Rezolute (RZLT) Restructuring Costs (2013 - 2026)
Rezolute's (RZLT) quarterly Restructuring Costs came in at $1.5 million in Q1 2026, down 19.86% year-on-year from $1.9 million in Q1 2025, and down 69.79% quarter-over-quarter from $5.0 million in Q4 2025.
Rezolute (RZLT) Restructuring Costs (2013 - 2026) Analysis & Trends
Rezolute has disclosed Restructuring Costs across 10 years of filings, most recently posting $1.5 million for Q1 2026.
- Restructuring Costs for Q1 2026 came in at $1.5 million, down 19.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.7 million (up 93.1% YoY), and the FY2025 annual result was $7.6 million, up 32.43% from the prior year.
- Restructuring Costs came in at $1.5 million for Q1 2026 at Rezolute, down from $5.0 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $5.0 million in Q4 2025 to a low of $1.5 million in Q1 2026.
- The 3-year median for Restructuring Costs is $1.9 million (2024), against an average of $2.5 million.
- Across the five-year window, Restructuring Costs jumped 167.75% in 2025 and dropped 19.86% in 2026, its largest moves.
- Rezolute's Restructuring Costs stood at $1.9 million in 2024, then soared by 167.75% to $5.0 million in 2025, then tumbled by 69.79% to $1.5 million in 2026.
- The last three Restructuring Costs figures came in at $1.5 million (Q1 2026), $5.0 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.87 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Mar 31, 2019 | 419,562.00 |
| Dec 31, 2018 | 291,721.00 |
| Sep 30, 2018 | 239,340.00 |
| Jun 30, 2018 | 277,151.00 |
| Mar 31, 2018 | 414,297.00 |
| Dec 31, 2017 | 318,272.00 |
| Sep 30, 2017 | 327,600.00 |
| Jun 30, 2017 | 291,202.00 |
| Mar 31, 2017 | 382,535.00 |
| Dec 31, 2016 | 301,520.00 |
| Sep 30, 2016 | 256,596.00 |
| Jun 30, 2016 | 203,277.00 |
| Mar 31, 2016 | 302,731.00 |